Senores Pharmaceuticals Ltd consolidated Q3FY26 profit at Rs. 33.58 crores

Senores Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2025.

Financial Results (Q3 FY2026) - QoQ Comparison

The company has reported total income of Rs. 178.34 crores during the period ended December 31, 2025 as compared to Rs. 167.17 crores during the period ended September 30, 2025.

The company has posted net profit / (loss) of Rs. 33.58 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 30.12 crores for the period ended September 30, 2025.

The company has reported EPS of Rs. 7.29 for the period ended December 31, 2025 as compared to Rs. 6.54 for the period ended September 30, 2025.

Financials	Q3 FY2026	Q2 FY2026	% Change
Total Income	₹ 178.34 crs	₹167.17 crs	6.68%
Net Profit	₹33.58 crs	₹30.12 crs	11.49%
EPS	₹7.29	₹6.54	11.47%

Financial Results (Q3 FY2026) - YoY Comparison

The company has reported total income of Rs. 178.34 crores during the period ended December 31, 2025 as compared to Rs.108.18 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.33.58 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.16.42 crores for the period ended December 31, 2024.

The company has reported EPS of Rs.7.29 for the period ended December 31, 2025 as compared to Rs.5.04 for the period ended December 31, 2024.

Financials	Q3 FY2026	Q3 FY2025	% Change
Total Income	₹ 178.34 crs	₹108.18 crs	64.85%
Net Profit	₹33.58 crs	₹16.42 crs	104.51%
EPS	₹7.29	₹5.04	44.64%

Financial Results (9 Months Ended FY2026) - YoY Comparison

The company has reported total income of Rs.486.84 crores during the 9 Months period ended December 31, 2025 as compared to Rs.291.53 crores during the 9 Months period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.84.86 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.40.37 crores for the 9 Months period ended December 31, 2024.

The company has reported EPS of Rs.18.43 for the 9 Months period ended December 31, 2025 as compared to Rs.12.14 for the 9 Months period ended December 31, 2024.

Financials	9 Months Ended FY2026	9 Months Ended FY2025	% Change
Total Income	₹486.84 crs	₹291.53 crs	66.99%
Net Profit	₹84.86 crs	₹40.37 crs	110.21%
EPS	₹18.43	₹12.14	51.81%

Shares of Senores Pharmaceuticals Limited was last trading in BSE at Rs. 806.55 as compared to the previous close of Rs. 790.25. The total number of shares traded during the day was 12558 in over 679 trades.

The stock hit an intraday high of Rs. 811.95 and intraday low of 770.30. The net turnover during the day was Rs. 9982139.00.

Source : Equity Bulls

Keywords

SenoresPharmaceuticals Q3FY26 Q3FY2026 9MFY26 9MFY2026 ResultUpdate